AbbVie Inc. Q4 2025 shows SKYRIZI/RINVOQ strength but diversification risks and M&A reliance. Click here to read this earnings analysis of ABBV stock.
To sustain academic integrity in an AI-present learning environment, educators must redesign assessment to foreground ...
Estimating the value of global investment in immunization programs is critical to helping decision makers plan and mobilize immunization programs and allocate resources required to realize their full ...
About 70 per cent of cases are prevented through cervical screening, according to cancer research, and the HPV vaccine is ...
Explore how quantum sensors are revolutionizing scientific measurement. Learn about superposition, entanglement, and high-precision data acquisition.
Roche remains a Buy, driven by strong pipeline progress and conservative valuation, with shares up 36% since my last recommendation. Learn more about RHHBY stock here.
Raghab Singh’s research advances structure-first AI models for healthcare, combining molecular geometry and language ...
Natalie McCormick, PhD, of the Rheumatology and Allergy Clinical Epidemiology Research (RACER) Center within the Division of ...
Investigators reviewed data from the SANO trial to assess long-term comparative effectiveness of active surveillance vs standard esophagectomy in patients with complete clinical response following ...
USD/JPY volatility builds as Japan and US services PMIs loom, with BoJ hike and Fed cut bets influencing near-term price ...
A salivary miRNA test for endometriosis shows high accuracy; however, experts debate whether it can replace laparoscopy.
Dengue and chikungunya, the two mosquito-borne diseases that frequently circulate at the same time, share the same Aedes ...